Patents by Inventor Morten Bang Nørgaard

Morten Bang Nørgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclopropyl derivatives as NK3 receptor antagonists
    Patent number: 7834008
    Abstract: The present invention relates to cyclopropyl derivatives of formula (I) and salt thereof. These compounds are NK3 receptor antagonists and may therefore be useful for treatment of diseases where the NK3 receptor is implicated, e.g. psychotic disorders.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: November 16, 2010
    Assignee: H. Lundbeck A/S
    Inventors: Jan Kehler, Tore Hansen, Anders Poulsen, Berith Bjørnholm, Thomas Ruhland, Morten Bang Nørgaard, Søren Møller Nielsen
  • Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
    Patent number: 7737170
    Abstract: The present invention relates to uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives of general formula (I): in the treatment of affective disorders.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: June 15, 2010
    Assignee: H. Lundbeck A/S
    Inventors: Jan Kehler, Karsten Juhl, Jimmy Sejberg, Morten Bang Nørgaard
  • Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
    Patent number: 7737171
    Abstract: The present invention relates to uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives of general formula (I): in the treatment of affective disorders.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: June 15, 2010
    Assignee: H. Lundbeck A/S
    Inventors: Jan Kehler, Karsten Juhl, Jimmy Sejberg, Morten Bang Nørgaard
  • 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
    Patent number: 7563908
    Abstract: The present invention relates to 2-(1H-indolylsulfanyl)-benzyl amine derivatives of general formula (I): and pharmaceutical compositions comprising the compounds useful as SSRIs.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: July 21, 2009
    Inventors: Jan Kehler, Karsten Juhl, Jimmy Sejberg, Morten Bang Nørgaard